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Celiac disease is an autoimmune disorder, caused by a
permanent intolerance to gluten contained in wheat and to
similar prolamines present in barley and rye. It is a common
disease as its prevalence, in Caucasian populations, is about
1%.There are several patterns of clinical presentation: typical
(with gastrointestinal symptoms), atypical (extraintestinal
manifestations), and silent forms, all characterized by typical
histological lesions in the small bowel mucosa. Nowadays
the gluten-free diet for life is the only therapy available for
CD. Considerable progress has beenmade due to advances in
molecular biology, which have allowed better understanding
of the genetic mechanisms involved in CD and the identifica-
tion of new pathogenetic pathways that have the potential to
be targeted by new drugs. In this special issue, we have invited
authors to contribute original papers that will stimulate
the continuing efforts to understand the pathogenesis and
heterogeneous clinical presentation of celiac disease.
Immunogenic peptides, created by deamidation of food-
derived gliadin peptides by small intestinal tissue transglu-
taminase, are presented by antigen-presenting cells, mostly
dendritic cells bearing HLA-DQ2 and DQ8 molecules, to
proinflammatory CD4+ T cells, activating them. E. Liu et al.
investigated peripheral T cell responses from young children
with newly diagnosed CD prior to treatment with a gluten-
free diet, finding that T cell reactivity is heterogeneous but
favors reactivity with 𝛼-gliadin epitopes more than 𝛾-gliadin.
Metabolomics is a rapidly emerging new concept in
science that appears to have relevant application also in the
field of celiac disease. In their meticulous review, A. Cal-
abro` et al. highlight the metabolomics perspective on celiac
disease. Furthermore, the growing recognition of the impor-
tant role of gut microbiota in the development of celiac
disease and other food-related disorders is addressed and
thoroughly reviewed.
Healing of the small bowel mucosa is directly dependent
on the adherence to the gluten-free diet, and its assessment
by noninvasive tools has been a long-time objective of
research in celiac disease, with the aim of establishing suitable
minimally invasive methods both for diagnosing and for
adequate follow-up of celiac disease and of the adequacy of
the gluten-free diet. In their study, E. Trigoni et al. concluded
that anti-endomysium antibodies had better ability, at least in
adult individuals, than anti-tissue transglutaminase to predict
celiac disease and to assess the gluten-free diet in the critical
period of the first semester after diagnosis and the beginning
of the diet.
Among the atypical clinical forms of CD, oral signs are
often neglected but could offer important diagnostic clues
in challenging diagnoses. Lesions in the oral mucosa or
defects in dental enamel can in fact be present in celiac
patients.The paper ofM. Erriu et al., evaluating oral signs and
different DQ2 haplotypes, highlights the fundamental role
that dentists can play in early recognition of CD.
It is well known that untreated celiac disease patients
develop specific serum autoantibodies against transglutam-
inase 2. Recently it has been discovered that corresponding
circulating antibodies against transglutaminase 6 (TG6) may
play a role in particular gluten-related neurological disorders.
In their study, R. Stenberg et al. demonstrate that the presence
of anti-TG6 antibodies is increased in subjects with early
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neurological injury resulting in cerebral palsy, suggesting
that an early brain insult may lead to subsequent TG6 auto-
immunity.
Due to their common genetic background, celiac disease,
type 1 diabetes mellitus, and autoimmune thyroiditis are
often associated. M. van der Pals et al. confirmed three
times higher prevalence of thyroid autoimmunity markers
(autoantibodies against thyroid peroxidase) in celiac disease
children compared with 12-year-old healthy controls but
no difference in thyroid autoimmunity between clinically
detected and screen-detected celiac disease children.
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